Category: Pharmaceuticals
Global Pharmaceuticals
-
Transdermal Scopolamine
... CAGR of 5.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$141.9 Million While China is Forecast to Grow at 5.1% CAGR The Transdermal Scopolamine market in the U.S. is estimated at ... Read More
-
Brain Computer Interface
... at a CAGR of 10.3% over the analysis period 2024-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Child Resistant Closures
... at a CAGR of 4.2% over the analysis period 2024-2030. Push and Turn Closures, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.8 Billion by the ... Read More
-
Spring and Wire Products
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Springs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$47.0 Billion by the end ... Read More
-
Automotive Wiper Component Aftermarket
... 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Wiper Blade Component, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$6.5 Billion by ... Read More
-
Flea and Tick Products
... 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Chewable Products, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$7.3 Billion by the ... Read More
-
Hospitals and Outpatient Care Centers
... Trillion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.1 Trillion While China is Forecast to Grow at 7.6% CAGR The Hospitals and Outpatient ... Read More
-
Small Bone and Joint Orthopedic Devices
... reach US$20.4 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Fracture Fixation & Replacement Systems, one of the segments analyzed in the report, is expected to record a 7.7% ... Read More
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate Material, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion ... Read More
-
Sports Management Software
... at a CAGR of 13.2% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$8.2 Billion by the end of ... Read More
-
Brachytherapy
... 4.3% over the analysis period 2024-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis ... Read More
-
Tangential Flow Filtration
... at a CAGR of 12.0% over the analysis period 2024-2030. Single-Use Systems, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.0 Billion by the end of ... Read More
-
Semi-Automatic Filling Equipment
... at a CAGR of 6.6% over the analysis period 2024-2030. Food & Beverages End-Use, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$2.0 Billion by the ... Read More
-
Vancomycin
... 4.9% over the analysis period 2024-2030. Lung Infection Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis period. ... Read More
-
Potassium Bromide
... CAGR of 4.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$8.5 Million While China is Forecast to Grow at 7.8% CAGR The Potassium Bromide market in the U.S. is estimated at ... Read More
-
Venturi Masks
... CAGR of 11.5% over the analysis period 2024-2030. COPD Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of the analysis ... Read More
-
Insulin Pens
... CAGR of 7.2% over the analysis period 2024-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of the ... Read More
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
... to a number of important factors. The growing requirement for point-of-care diagnostics is one of an important factor. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like ... Read More
-
Implantable Drug Delivery Devices
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$9.8 Billion by the ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2024-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Walnut
... 2.9% over the analysis period 2024-2030. Black Walnuts, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$570.1 Million by the end of the analysis period. Growth ... Read More
-
Animal Proteins
... CAGR of 6.9% over the analysis period 2024-2030. Food & Beverage Application, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.6 Billion by the end of ... Read More
-
Polyethylene Glycol Market by Grade, Form (Liquid, White wax, Flake/Powder), Package Size (Drums, Bulk Container, Glass Bottles), End-Use Industry (Pharmaceutical, Cosmetics & Personal care, Food & Beverage, Industrial) & Region - Global Forecast to 2029
... widely used for drug formulations and delivery systems in pharmaceutical industries. It enhances the solubility and bioavailability of poorly soluble drugs. Additionally, due to its low toxicity and non-irritating properties it is widely used in ... Read More
-
Particle Therapy
... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Patient Monitoring Devices
... at a CAGR of 7.5% over the analysis period 2024-2030. Blood Glucose Monitoring Device, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 Billion by the ... Read More
Research Assistance
